|
Originally published In Press as doi:10.1074/jbc.M206351200 on August 19, 2002
J. Biol. Chem., Vol. 277, Issue 43, 40567-40574, October 25, 2002
Shiga-like Toxin Inhibition of FLICE-like Inhibitory Protein
Expression Sensitizes Endothelial Cells to Bacterial
Lipopolysaccharide-induced Apoptosis*
Ryan D.
Erwert ,
Robert K.
Winn§,
John M.
Harlan , and
Douglas
D.
Bannerman¶
From the Departments of Medicine and
§ Surgery, University of Washington School of Medicine,
Seattle, Washington 98104 and ¶ Immunology and Disease Resistance
Laboratory, United States Department of Agriculture-Agricultural
Research Service, Beltsville, Maryland 20705
Shiga-like toxin (SLT) has been implicated in the
pathogenesis of hemolytic uremic syndrome and its attendant endothelial cell (EC) injury. Key serotypes of Escherichia coli produce
SLT-1 in addition to another highly pro-inflammatory molecule,
lipopolysaccharide (LPS). It has previously been established that SLT-1
induces EC apoptosis and that LPS enhances this effect. LPS alone has
no affect on human EC viability, and the mechanism for this enhancement remains unknown. In the present report, we demonstrate that SLT-1 sensitizes EC to LPS-induced apoptosis. Pretreatment with SLT-1 sensitized EC to LPS-induced apoptosis, whereas pretreatment with LPS
did not influence SLT-1-induced apoptosis. SLT-1 exposure resulted in
decreased expression of FLICE-like inhibitory protein (FLIP), an
anti-apoptotic protein that has previously been shown to block
LPS-induced apoptosis. This SLT-1-mediated decrease in FLIP expression
preceded the onset of apoptosis elicited by SLT-1 alone or in
combination with LPS. SLT-1-mediated decrements in FLIP expression
correlated in a dose- and time-dependent manner with
sensitization to LPS-induced apoptosis. Finally, transient or stable
overexpression of FLIP protected against LPS enhancement of
SLT-1-induced apoptosis, and this protection corresponded with sustained expression of FLIP. Together, these data suggest that SLT-1
sensitizes EC to LPS-induced apoptosis by inhibiting FLIP expression.
*
This work was supported by National Institutes of Health
Grants GM07037, GM42686, HL18645, and HL03174.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Immunology and
Disease Resistance Laboratory, USDA Agricultural Research Service/ANRI, BARC-East, Bldg. 1040, Rm. 2, Beltsville, MD 20705-2350. Tel.: 301-504-5066; Fax: 301-504-9498; E-mail:
dbanner@anri.barc.usda.gov.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Fujii, K. Wood, F. Matsuda, B. A. Carneiro-Filho, K. H. Schlegel, T. Yutsudo, B. Binnington-Boyd, C. A. Lingwood, F. Obata, K. S. Kim, et al.
Shiga Toxin 2 Causes Apoptosis in Human Brain Microvascular Endothelial Cells via C/EBP Homologous Protein
Infect. Immun.,
August 1, 2008;
76(8):
3679 - 3689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stefanescu, D. Bassett, R. Modarresi, F. Santiago, M. Fakruddin, and J. Laurence
Synergistic interactions between interferon-{gamma} and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis
Blood,
July 15, 2008;
112(2):
340 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Damico, A. Chesley, L. Johnston, E. P. Bind, E. Amaro, J. Nijmeh, B. Karakas, L. Welsh, D. B. Pearse, J. G. N. Garcia, et al.
Macrophage Migration Inhibitory Factor Governs Endothelial Cell Sensitivity to LPS-Induced Apoptosis
Am. J. Respir. Cell Mol. Biol.,
July 1, 2008;
39(1):
77 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Wang, I. O. Akinci, C. M. Baker, D. Urich, A. Bellmeyer, M. Jain, N. S. Chandel, G. M. Mutlu, and G. R. S. Budinger
The Intrinsic Apoptotic Pathway Is Required for Lipopolysaccharide-Induced Lung Endothelial Cell Death
J. Immunol.,
August 1, 2007;
179(3):
1834 - 1841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakayama, R. G. Pergolizzi, and R. G. Crystal
Gene Transfer-Mediated Pre-mRNA Segmental Trans-splicing As a Strategy to Deliver Intracellular Toxins for Cancer Therapy
Cancer Res.,
January 1, 2005;
65(1):
254 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Bannerman, K. T. Eiting, R. K. Winn, and J. M. Harlan
FLICE-Like Inhibitory Protein (FLIP) Protects Against Apoptosis and Suppresses NF-{kappa}B Activation Induced by Bacterial Lipopolysaccharide
Am. J. Pathol.,
October 1, 2004;
165(4):
1423 - 1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Bannerman and S. E. Goldblum
Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis
Am J Physiol Lung Cell Mol Physiol,
June 1, 2003;
284(6):
L899 - L914.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|